Abstract:Background Epigenetic alternation is a common contributing factor to neoplastic transformation. Although previous studies have reported a cluster of aberrant promoter methylation changes associated with silencing of tumor suppressor genes, little is known concerning their sequential DNA methylation changes during the carcinogenetic process. The aim of the present study was to address a genome-wide search for identifying potentially important methylated changes and investigate the onset and pattern of methylation changes during the progression of colorectal neoplasia. Methods A three-phase design was employed in this study. In the screening phase, DNA methylation profile of 12 pairs of colorectal cancer (CRC) and adjacent normal tissues was analyzed by using the Illumina MethylationEPIC BeadChip. Significant CpG sites were selected based on a cross-validation analysis from The Cancer Genome Atlas (TCGA) database. Methylation levels of candidate CpGs were assessed using pyrosequencing in the training dataset (tumor lesions and adjacent normal tissues from 46 CRCs) and the validation dataset (tumor lesions and paired normal tissues from 13 hyperplastic polyps, 129 adenomas, and 256 CRCs). A linear mixed-effects model was used to examine the incremental changes of DNA methylation during the progression of colorectal neoplasia. Results The comparisons between normal and tumor samples in the screening phase revealed an extensive CRC-specific methylomic pattern with 174,006 (21%) methylated CpG sites, of which 22,232 (13%) were hyermethylated and 151,774 (87%) were hypomethylated. Hypermethylation mostly occurred in CpG islands with an overlap of gene promoters, while hypomethylation tended to be mapped far away from functional regions. Further cross validation analysis from TCGA dataset confirmed 265 hypermethylated promoters coupling with downregulated gene expression. Among which, hypermethylated changes in MEEPD2 promoter was successfully replicated in both training and validation phase. Significant hypermethylation appeared since precursor lesions with an extensive modification in CRCs. The linear mixed-effects modeling analysis found that a cumulative pattern of MPPED2 methylation changes from normal mucosa to hyperplastic polyp to adenoma, and to carcinoma ( P < 0.001). Conclusions Our findings indicate that epigenetic alterations of MPPED2 promoter region appear sequentially during the colorectal neoplastic progression. It might be able to serve as a promising biomarker for early diagnosis and stage surveillance of colorectal tumorigenesis.

Promoter Methylation of Death-Associated Protein Kinase Gene and Calgranulin B Mrna As Indicators of Therapeutic Effect in Barrett′s Esophagus

Expression of DAPK and calgranulin B in mucosa of Barrett's esophagus

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer

Promoter hypermethylation of GALR1 acts as an early epigenetic susceptibility event in colorectal carcinogenesis

APC Promoter Methylation in Gastrointestinal Cancer

Methylation of LAPTM4B Promoter Region Influences Its mRNA Expression in Esophageal Cancer

Epigenetic Inactivation Of Deleted In Lung And Esophageal Cancer 1 Gene By Promoter Methylation In Gastric And Colorectal Adenocarcinoma

Epigenetic Regulation of Death-Associated Protein Kinase Expression in Primary Gastric Cancers from Chinese Patients

Methylation profiling of rectal cancer identifies novel markers of early-stage disease

A Systematic Review and Meta-Analysis of the Treatment for Barrett’s Esophagus

Band Ligation-Assisted Endoscopic Mucosal Resection for Barrett Esophagus:Killing Two Birds with One Stone

Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus

Abstract 1679: Genome-wide Methylation Analysis in Barrett's Esophagus and Esophageal Adenocarcinoma

Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer

Genome-wide Methylation Analysis Shows Similar Patterns in Barrett’s Esophagus and Esophageal Adenocarcinoma

Quantitative Assessment Of Akap12 Promoter Methylation In Colorectal Cancer Using Methylation-Sensitive High Resolution Melting Correlation With Duke'S Stage

Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma

Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer

Quantitative assessment of gene methylation and their impact on clinical outcome in gastric cancer.

Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma

Rates of Recurrent Intestinal Metaplasia and Dysplasia After Successful Endoscopic Therapy of Barrett's Neoplasia by EMR vs ESD and Ablation: A Large North American Multicenter Cohort